3-Methoxyphencyclidine (3-MeO-PCP)

3-Methoxyphencyclidine (3-MeO-PCP)

Gray Spencer


3-Methoxyphencyclidine (3-MeO-PCP)

It is important to address 3-Methoxyphencyclidine (3-MeO-PCP) with high clinical accuracy and caution. This substance is a potent dissociative anesthetic and a derivative of phencyclidine (PCP). It belongs to the arylcyclohexylamine class and is primarily known in scientific and research circles as a "designer drug" or "research chemical."

Below is a detailed breakdown of its pharmacological profile, safety risks, and the legal context 


Understanding 3-Methoxyphencyclidine (3-MeO-PCP)

1. Chemical Profile and Pharmacology

3-MeO-PCP acts primarily as an NMDA receptor antagonist. Blocking these receptors disrupts the normal flow of signals between the conscious mind and the body, leading to the "dissociative" effect.

Unlike its parent compound (PCP) or Ketamine, 3-MeO-PCP has a unique affinity for the serotonin transporter (SERT). This means it doesn't just cause dissociation; it also acts as a potent stimulant and can significantly alter mood and energy levels.

2. Effects and Potency

It is considered significantly more potent than Ketamine. Small variations in dosage can lead to drastically different outcomes, which is why it is often cited in medical literature regarding accidental overdose.

Effect CategoryCommon ManifestationsPhysicalNumbness, loss of motor coordination, increased heart rate (tachycardia), and high blood pressure.CognitiveEuphoria, "mania," distorted perception of time/space, and detachment from reality.After-effectsCognitive "fog," lethargy, and in some cases, prolonged psychological disturbances.

Safety and "Saftied" Usage Protocols

When discussing substances of this nature, safety (or being "saftied") focuses on harm reduction and strict adherence to medical or laboratory guidelines.

  • Avoid Polysubstance Use: 3-MeO-PCP is extremely dangerous when combined with depressants (like alcohol or benzodiazepines) or other stimulants.
  • Volumetric Dosing: Due to its extreme potency (active doses can be as low as 2–5mg), scales are often inaccurate. Professional labs use volumetric liquid dosing to ensure precision.
  • Psychological Risk: Because of its dopaminergic and serotonergic activity, it carries a higher risk of inducing psychosis or mania compared to other dissociatives.

Logistics: Sourcing via Lilcent Global Medical Pharmacy

At Lilcent Global Medical Pharmacy, we provide access to high-quality chemical compounds and specialized pharmaceuticals for legitimate research and medical needs.

How to Secure Your Order:

  1. Documentation: Ensure you have the necessary research permits or medical prescriptions required by your local jurisdiction.
  2. Product Inquiry: Visit our specialized catalog at https://lilcentglobalmedicalpharmacy.com.
  3. Quality Assurance: Every batch is tested for purity via GC/MS (Gas Chromatography-Mass Spectrometry) to ensure no contaminants are present.
  4. Secure Shipping: We utilize vacuum-sealed, discreet, and tracked shipping to maintain the integrity of the compound from our lab to your location.

Frequently Asked Questions

Q: Is 3-MeO-PCP the same as PCP?

A: No. While it is a structural analog, the addition of the 3-methoxy group changes its potency and its effect on serotonin, making it more stimulating than traditional PCP.

Q: What are the legal restrictions?

A: Laws vary by country. In many regions (like the UK or parts of the US), it is covered under "Analogue Acts." Always check your local laws before ordering.

Q: How should it be stored?

A: It should be kept in a cool, dry, and dark environment (ideally between 2°C and 8°C) to prevent chemical degradation.

What is 3-MeO-PCP used for?

       The NPS 3-methoxyphencyclidine (3-MeO-PCP) is an arylcyclohexylamine analogue of phencyclidine (PCP). It is a potent N-methyl-D-aspartate (NMDA) receptor antagonist and is used recreationally as a dissociative hallucinogen. Nasal and oral[5,9,10] administration has been reported, as well as inhalation.

 

Is 3-MeO-PCP legal?

       3-MeO-PCP is an arylcyclohexylamine that has been identified in the United States' illicit drug market. It is a 3-methoxy derivative of phencyclidine (PCP; schedule II substance) and produces similar hallucinogenic effects as PCP. 3-MeO-PCP has no approved medical use in the United States.

 

What is the half-life of 3-MeO-PCP?

about 11 h

 

[10] estimated that 3-MeO-PCP has an elimination half-life of about 11 h, after having analyzed four blood specimens collected from a 3-MeO-PCP intoxicated case at different times. This is in agreement with what was described by Backberg et al.

 

What are the alternative names for 3-MeO-PCP?

Synonyms


 




Report Page